Dosing Recommendations for Cefepime, Metronidazole (Flagyl), and Vancomycin
For patients with normal renal function, dose vancomycin at 15-20 mg/kg every 8-12 hours targeting trough levels of 15-20 mg/L, cefepime at 2 g every 8 hours, and metronidazole at 500 mg every 8-12 hours, with aggressive renal dose adjustments required for all three agents as creatinine clearance declines.
Vancomycin Dosing
Normal Renal Function
- Dose: 15-20 mg/kg (actual body weight) every 8-12 hours 111
- Target trough: 15-20 mg/L for serious infections (bacteremia, endocarditis, osteomyelitis, meningitis, hospital-acquired pneumonia) 1
- Infuse doses >1 g over 1.5-2 hours to reduce infusion-related reactions 1
- Measure trough before the 4th dose for prolonged therapy 1
Renal Impairment Considerations
Critical caveat: Vancomycin requires individualized pharmacokinetic adjustments based on actual renal function. The guideline evidence predates modern AUC-targeted dosing, but the weight-based approach remains foundational 11. Recent data suggests that in overweight/obese patients with renal dysfunction, both total body weight AND renal function must guide dosing 2.
Monitoring
- Monitor trough levels for patients receiving aggressive dosing (targeting 15-20 mg/L) or those at high nephrotoxicity risk 1
- Do NOT monitor peak levels - no evidence this reduces nephrotoxicity 1
- Watch for nephrotoxicity: ≥2-3 consecutive creatinine increases of 0.5 mg/dL or 150% from baseline 1
Cefepime Dosing
Normal Renal Function (CrCl >60 mL/min)
Standard dosing from FDA label 3:
- Complicated intra-abdominal infections (with metronidazole): 2 g every 8-12 hours 43
- Febrile neutropenia: 2 g every 8 hours
- Pneumonia: 1-2 g every 8-12 hours
- Severe UTI: 2 g every 12 hours
- Infuse over 30 minutes 3
Renal Dose Adjustments
Mandatory adjustments for CrCl ≤60 mL/min 3:
| CrCl (mL/min) | Standard 2g q8h becomes | Standard 2g q12h becomes |
|---|---|---|
| 30-60 | 2g q12h | 2g q24h |
| 11-29 | 2g q24h | 1g q24h |
| <11 | 1g q24h | 500mg q24h |
| Hemodialysis | 1g day 1, then 500mg q24h (after dialysis) | 1g q24h (after dialysis) |
Important: For augmented renal clearance (CrCl 120-180 mL/min), consider extending infusion to 4 hours to maintain adequate exposure 56.
Combination Therapy Note
When using cefepime with metronidazole for intra-abdominal infections, the guideline recommends 2 g every 8-12 hours for 7-10 days 43. The nephrotoxicity risk is significantly lower with vancomycin-cefepime combinations compared to vancomycin-piperacillin/tazobactam 7.
Metronidazole (Flagyl) Dosing
Standard Dosing
- 500 mg every 8-12 hours OR 1500 mg every 24 hours 4
- For intra-abdominal infections: typically 500 mg every 8 hours 4
Renal Impairment
Critical point: Metronidazole does NOT require dose adjustment in renal failure 8.
- Renal clearance is minimal (1.4 mL/min in acute renal failure) 8
- Non-renal clearance remains intact at ~54 mL/min 8
- Standard dosing of 500 mg twice daily maintains therapeutic levels even in acute renal failure 8
- Metabolites may accumulate but parent drug levels remain adequate
Nephrotoxicity Risk Management
Major concern: The combination of vancomycin with certain beta-lactams increases nephrotoxicity risk.
Evidence-Based Hierarchy (Lowest to Highest Risk):
- Vancomycin + Meropenem (lowest risk)
- Vancomycin + Cefepime (low-moderate risk)
- Vancomycin + Piperacillin-Tazobactam (highest risk - OR 1.37 for AKI vs. cefepime, OR 1.27 vs. meropenem) 7
Clinical implication: When empiric broad-spectrum coverage requires vancomycin plus an anti-pseudomonal beta-lactam, prefer cefepime or meropenem over piperacillin-tazobactam to minimize nephrotoxicity, especially in ICU patients and those requiring >3-4 days of therapy 7.
Duration of Therapy
For complicated intra-abdominal infections, limit antimicrobial therapy to 4-7 days unless source control is inadequate 4. Longer durations have not shown benefit and increase toxicity risk.